We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Novel Point-of-Care Device Simultaneously Detects Bacterial Growth and Tests Antibiotic Susceptibility

By LabMedica International staff writers
Posted on 02 Mar 2020
A novel paper-based point-of-care device that combines detection of pathogenic bacteria with determination of antibiotic susceptibility is expected to reduce the number of unnecessary antibiotic prescriptions and aid in the on-going struggle to prevent development of antibiotic resistance.

Antimicrobial resistance (AMR) has been identified by the World Health Organization as a global threat that currently claims at least 25,000 deaths each year in Europe and 700,000 world-wide. More...
The number of fatalities attributed to AMR is projected to reach 10 million per year between 2015 and 2050. Therefore, there is an urgent need for low-cost but reliable point-of-care diagnostics for early screening of infections especially in developing countries lacking in health care infrastructure and trained personnel.

To this end, investigators at the University of Southampton (United Kingdom) developed a laser-patterned paper-based device for detection and susceptibility testing of Escherichia coli, the main cause of urinary tract infections, via a simple visually observable color change.

The test device comprises three layers - a top paper layer containing four common antibiotics in confined rectangular areas, an absorbent paper in the middle, and an agar gel-containing base layer, all sealed in a plastic casing.

A test is performed by adding a liquid sample (such as urine) to a small paper tab, which is then covered with tape to prevent drying out or contamination. The sample diffuses across the middle paper layer and through the four rectangles containing the test antibiotics (amoxicillin, ciprofloxacin, gentamicin and nitrofurantoin). If bacteria are present in the sample, their growth will cause the paper to turn blue. If the bacteria are susceptible to one (or more) of the antibiotics, a clear patch caused by growth inhibition will be seen around the corresponding rectangle.

In comparison studies using artificial urine spiked with E.coli, the new paper-based device gave results similar to those obtained by growth in petri dishes with agar gel.

"By enabling doctors to quickly determine if an infection is caused by bacteria, and if the bacteria are resistant to four common antibiotics, this device could cut down on unnecessary antibiotic prescriptions and help fight the growing threat of antibiotic resistance," said senior author Dr. Collin Sones, associate professor of optoelectronics research at the University of Southampton.

The device for simultaneous detection and antibiotic-resistance testing of bacterial infections was described in the March 15, 2020, online edition of the journal Biosensors and Bioelectronics.

Related Links:
University of Southampton


New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Celiac Disease Test
Anti-Gliadin IgG ELISA
New
Integrated Biochemical & Immunological System
Biolumi CX8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.